As a component of the Tuberculosis Structural Genomics Consortium, this project will focus on structural and biochemical characterization of key metabolic and biosynthetic enzymes in three broad categories. 1) We will determine the structures of several enzymes involved in energy production, given the need of the organism to adapt to metabolism of different carbon sources inside host macrophages, especially enzymes at key choice points where flux of metabolites between pathways is controlled. 2) We will determine the structures of enzymes required for biosynthesis of essential amino acids and co-factors, which are thought to be restricted in the nutrient-limiting environment of the phagosome. 3) Finally, we will determine the structures of enzymes that synthesize mycolic acids, polyketides, and other lipid components of the cell wall. Each of these pathways represents a critical vulnerability in the organism that could be exploited for future drug discovery. Our goal is not just to solve the structures of these proteins, but also to obtain co-crystal structures of complexes with inhibitors, which provides important information on active-site interactions for subsequent drug design. Hence, for most of our targets, we will perform screening of small-molecule libraries to identify inhibitors as ligands for co-crystallization. The inhibitory compounds we discover will also be useful as chemical tools of value for many other purposes, such as probing function in cell and validating essentiality by chemical knock-down. All structural and chemical data generated will be made available to the public to stimulate future drug discovery for tuberculosis.

Public Health Relevance

The protein crystal structures we propose to solve will not only contribute to our understanding of the function and role of these proteins in M. tuberculosis, but they will also provide important structural information for future drug discovery. Structures of complexes with inhibitors are needed to reveal active-site interactions for designing more potent drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI095208-03
Application #
8711234
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
3
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Texas A&M University
Department
Type
DUNS #
City
College Station
State
TX
Country
United States
Zip Code
77845
Costa, Diego L; Namasivayam, Sivaranjani; Amaral, Eduardo P et al. (2016) Pharmacological Inhibition of Host Heme Oxygenase-1 Suppresses Mycobacterium tuberculosis Infection In Vivo by a Mechanism Dependent on T Lymphocytes. MBio 7:
Wagner, Jonathan M; Chan, Sum; Evans, Timothy J et al. (2016) Structures of EccB1 and EccD1 from the core complex of the mycobacterial ESX-1 type VII secretion system. BMC Struct Biol 16:5
Diaz-Ochoa, Vladimir E; Lam, Diana; Lee, Carlin S et al. (2016) Salmonella Mitigates Oxidative Stress and Thrives in the Inflamed Gut by Evading Calprotectin-Mediated Manganese Sequestration. Cell Host Microbe 19:814-25
Olive, Andrew J; Sassetti, Christopher M (2016) Metabolic crosstalk between host and pathogen: sensing, adapting and competing. Nat Rev Microbiol 14:221-34
Bajaj, R Alexandra; Arbing, Mark A; Shin, Annie et al. (2016) Crystal structure of the toxin Msmeg_6760, the structural homolog of Mycobacterium tuberculosis Rv2035, a novel type II toxin involved in the hypoxic response. Acta Crystallogr F Struct Biol Commun 72:863-869
Lovewell, Rustin R; Sassetti, Christopher M; VanderVen, Brian C (2016) Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection. Curr Opin Microbiol 29:30-6
Cheng, Yu-Shan; Sacchettini, James C (2016) Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance. Biochemistry 55:1107-19
Dragset, Marte S; Poce, Giovanna; Alfonso, Salvatore et al. (2015) A novel antimycobacterial compound acts as an intracellular iron chelator. Antimicrob Agents Chemother 59:2256-64
Kieser, Karen J; Boutte, Cara C; Kester, Jemila C et al. (2015) Phosphorylation of the Peptidoglycan Synthase PonA1 Governs the Rate of Polar Elongation in Mycobacteria. PLoS Pathog 11:e1005010
Long, Jarukit E; DeJesus, Michael; Ward, Doyle et al. (2015) Identifying essential genes in Mycobacterium tuberculosis by global phenotypic profiling. Methods Mol Biol 1279:79-95

Showing the most recent 10 out of 37 publications